Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Phase III PLATO study proves that ticagrelor is more effective than clopidogrel

New data from the phase III PLATO study showed that ticagrelor (BRILINTA((TM))) provided greater reduction of cardiovascular (CV) events (composite of CV death, heart attack and stroke) than clopidogrel (9.02% vs. 10.65%,>

25 Sep 2009

Researchers to use Intravenous Immune Globulin for slowing AD progression

Researchers from the Memory and Cognition Center at University Hospitals Case Medical Center will begin testing an intriguing new approach to slowing down the progression of Alzheimer's Disease (AD) using Intravenous Immune Globulin (IGIV), also known as gammaglobulin.

25 Sep 2009

Profile of Grady Memorial Hospital highlights the difficulties faced by safety net facilities

The New York Times: Illegal immigrants say an effort to close the dialysis center at Grady Memorial Hospital in Atlanta could synch their only source of care. The closure may foreshadow broader problems "safety-net" hospitals could face under the health care overhaul.

25 Sep 2009

Caliper Life Sciences unveils XenoLight Rediject reagents series at WMIC

Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today introduced a series of XenoLight Rediject reagents at the World Molecular Imaging Congress (WMIC) in Montreal, Canada. Rediject D-Luciferin Ultra is the latest in an expanding range of XenoLight reagents for Caliper's IVIS optical imaging systems.

25 Sep 2009

Perot Systems to provide Revenue Cycle services to the West Georgia Health System

West Georgia Health System and Perot Systems today announced that Perot Systems will provide Revenue Cycle services to the LaGrange, Georgia-based hospital organization. The agreement will enable WGHS to utilize Perot Systems' revenue cycle technology and its proven best practices for revenue cycle improvements.

25 Sep 2009

Senators urge the CMS to spare funding cuts for radiation oncology services

Cancer physicians and cancer care advocates applauded a bipartisan letter led by Senators Richard Burr (R-NC) and Blanche Lincoln (D-AR) sent to Health and Human Services Secretary Kathleen Sebelius yesterday urging that the Centers for Medicare and Medicaid Services (CMS) spare life-saving radiation oncology services from a major Medicare funding cut proposed for diagnostic imaging services. The 32 Senators signing the letter stated their unanimous concern that these funding cuts could force freestanding and community-based cancer centers to shut down, thereby limiting access to care for seniors - particularly in rural areas.

25 Sep 2009

Huachansu may slow cancer progression

Huachansu, a Chinese medicine that comes from the dried venom secreted by the skin glands of toads, has tolerable toxicity levels, even at doses eight times those normally administered, and may slow disease progression in some cancer patients, say researchers from The University of Texas M. D. Anderson Cancer Center.

25 Sep 2009

FDA grants priority review for Cephalon's sNDA

Cephalon, Inc. today announced the U.S. Food and Drug Administration (FDA) has granted a priority review for its supplemental New Drug Application (sNDA) for NUVIGIL(R) (armodafinil) Tablets [C-IV], which was filed in June of this year.

25 Sep 2009

CTRC commences patient enrolment in Phase 2 clinical trial of REOLYSIN for metastatic melanoma

Oncolytics Biotech Inc. announced today that the Cancer Therapy Research Center at the University of Texas Health Science Center (CTRC) has started patient enrolment in a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with paclitaxel and carboplatin in patients with metastatic melanoma.

24 Sep 2009

Study compares benefits of laparoscopic and traditional open surgery for prostate cancer

The more things change, the more they stay the same, as the proverb goes. A study appearing in an upcoming edition of The Journal of Oncology appears to prove just that. The study compares the benefits of laparoscopic surgery versus traditional open surgery in the treatment of prostate cancer. With traditional surgery, surgeons remove the prostate gland via an incision below the belly button.

24 Sep 2009

Research study links cancer to excess body weight

At least 124,000 new cancers in 2008 in Europe may have been caused by excess body weight, according to estimates from a new modelling study. The proportion of cases of new cancers attributable to a body mass index of 25kg/m2 or more were highest among women and in central European countries such as the Czech Republic, Latvia, Slovenia and Bulgaria.

From The University of Manchester 24 Sep 2009

Phase II study of OPAXIO to be revealed

Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that data from a Phase II study from Brown University of OPAXIO(TM) (paclitaxel poliglumex) combined with standard cisplatin and concurrent radiation in patients with advanced esophageal cancer will be presented by Dr. Howard Safran in an oral Proffered Papers session at the Annual Meeting of the International Society of Gastrointestinal Oncology in Philadelphia, Pennsylvania on Thursday, October 1st at 2:35 p.m. (Eastern time).

24 Sep 2009

Scientist reveals that selecting optimal radiation dosage for a patient is possible

An international group of scientists has taken the first step on the road to targeting radiotherapy dosage to individual patients by means of their genetic characteristics, a radiation oncologist told Europe's largest cancer congress, ECCO 15 - ESMO 34, in Berlin today (Thursday September 24). Professor Dirk de Ruysscher, from Maastricht University Medical Centre, Maastricht, The Netherlands, said that his team's work might provide the basis for personalised radiotherapy in which, with a simple blood test, doctors may be able to select the optimal radiation dose for a particular patient.

24 Sep 2009

CEL-SCI Corporation engages a CRO for clinical trial of its investigational LEAPS-H1N1 treatment

CEL-SCI Corporation (NYSE AMEX: CVM), a developer of vaccines and therapeutics for the treatment of infectious diseases and a late-stage oncology company, announced today that it has hired a full-service Clinical Research Organization (CRO) with an office in the Washington, D.C./Baltimore area to support its conduct of the upcoming clinical trial of its investigational LEAPS-H1N1 treatment.

24 Sep 2009

New method found for the treatment of pancreatic cancer

For the first time researchers have shown that by inhibiting the action of an enzyme called TAK-1, it is possible to make pancreatic cancer cells sensitive to chemotherapy, opening the way for the development of a new drug to treat the disease.

24 Sep 2009

AmeriChoice of Pennsylvania, Chester County Hospital sign agreement for access to hospital's facilities

AmeriChoice of Pennsylvania and Chester County Hospital have announced an agreement that will provide AmeriChoice Medicaid members access to the hospital’s inpatient and outpatient facilities.

24 Sep 2009

Cook Medical launches next-generation IVC filter delivery system for treating pulmonary embolism

Physicians can now navigate even the most tortuous anatomy with greater speed and safety with the next-generation inferior vena cava (IVC) filter delivery system introduced today by Cook Medical at TCT 2009. The release of the NavAlign™ delivery system marks the 20th anniversary of Cook’s first IVC filter and further advances the treatment of pulmonary embolism (PE), a life-threatening condition caused by blood clots in the lungs that affects thousands of Americans annually.

24 Sep 2009

Aegera Therapeutics raises $7 Million for additional working capital

Aegera Therapeutics, a clinical stage biotechnology company focussed on developing targeted therapeutics for oncology and pain, announced today the full drawdown of a $7 Million debt facility provided by Investissement Quebec.

24 Sep 2009

Twinkling nanostars improve optical imaging of tumors

Researchers at Purdue University have created magnetically responsive gold nanostars that may offer a new approach to biomedical imaging. The nanostars gyrate when exposed to a rotating magnetic field and can scatter light to produce a pulsating or "twinkling" effect. This twinkling allows them to stand out more clearly from noisy backgrounds such as those found in biological tissue. Alexander Wei, Ph.D., and Kenneth Ritchie, Ph.D., M.Sc., led the team that created the new gyromagnetic imaging method. The work appears in a paper published in the Journal of the American Chemical Society.

23 Sep 2009

Nanodiamonds advance anticancer gene therapy

Gene therapy holds promise in the treatment of cancer as well as a large number of other diseases. However, developing a scalable system for delivering genes to cells both efficiently and safely has been challenging. Now, two teams of researchers have developed versatile nanotechnology-enabled platforms that could get therapeutic genes safely and efficiently into cancer cells.

23 Sep 2009

Oncology News and Research

Further Reading

Phase III PLATO study proves that ticagrelor is more effective than clopidogrel

Researchers to use Intravenous Immune Globulin for slowing AD progression

Profile of Grady Memorial Hospital highlights the difficulties faced by safety net facilities

Caliper Life Sciences unveils XenoLight Rediject reagents series at WMIC

Perot Systems to provide Revenue Cycle services to the West Georgia Health System

Senators urge the CMS to spare funding cuts for radiation oncology services

Huachansu may slow cancer progression

FDA grants priority review for Cephalon's sNDA

CTRC commences patient enrolment in Phase 2 clinical trial of REOLYSIN for metastatic melanoma

Study compares benefits of laparoscopic and traditional open surgery for prostate cancer

Research study links cancer to excess body weight

Phase II study of OPAXIO to be revealed

Scientist reveals that selecting optimal radiation dosage for a patient is possible

CEL-SCI Corporation engages a CRO for clinical trial of its investigational LEAPS-H1N1 treatment

New method found for the treatment of pancreatic cancer

AmeriChoice of Pennsylvania, Chester County Hospital sign agreement for access to hospital's facilities

Cook Medical launches next-generation IVC filter delivery system for treating pulmonary embolism

Aegera Therapeutics raises $7 Million for additional working capital

Twinkling nanostars improve optical imaging of tumors

Nanodiamonds advance anticancer gene therapy

Cancer Research eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News